InvestorsHub Logo
Followers 51
Posts 3078
Boards Moderated 0
Alias Born 05/11/2016

Re: FELLER post# 31511

Thursday, 01/05/2017 9:09:10 AM

Thursday, January 05, 2017 9:09:10 AM

Post# of 203917
Great website OWNTHEFLOAT.COM


OWC Pharmaceutical Research Corp. engaged in the business, through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of non-psychoactive medical cannabis specifically designed for the treatment of several illnesses/medical conditions. Under the direction of Dr. Yehuda Baruch, our Director of Research and Regulatory Affairs, the Company has identified and prioritized several conditions that it believes will respond positively to cannabis-based therapies using specific dosages administered through soluble pills taken orally. Our initial focus will include PTSD, psoriasis, multiple myeloma and topical treatment of burns. Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies. Through our collaboration agreements, we are conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.